title: Hodgkin lymphoma following adalimumab for the treatment of Crohn's disease in an adolescent.
authors.affiliation: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Lucile Packard Children's Hospital, Stanford University, 750 Welch Rd. Suite 116, Palo Alto, CA, USA, aar239@stanford.edu.
authors.forename: Alexis A
authors.initials: AA
authors.lastname: Rodriguez
authors.forename: John
authors.initials: J
authors.lastname: Kerner
authors.forename: Sandra
authors.initials: S
authors.lastname: Luna-Fineman
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Berry
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068879:Adalimumab